Our facility provides stem cell derivation and gene-editing services to researchers worldwide. We are a team of highly experienced stem cell and molecular biologists with over 40 years of combined experience to generate standard and gene-edited iPSC lines in a manner that is both rapid and cost-effective.
A unique feature of our facility is the use of a streamlined one-step gene-editing/reprogramming methodology for extremely rapid and efficient generation of clonally derived gene-edited iPSC lines from primary patient fibroblasts or blood.
We liaise with researchers to devise the ideal strategy for achieving optimal gene-editing outcomes, including gene knock-out, knock-in or gene-correction, based upon the ever-expanding number of CRISPR/Cas9-based tools available. We also have an extensive collection of hPSC lines.